【摘 要】
：
Monitoring of minimal residual disease (MRD) has become a strong diagnostic tool in acute lymphoblastic leukemia (ALL).It is used for risk adapted therapy and for the recognition of pending relapses.I
【机 构】
：
University Children's Hospital Ulm Germany
【出 处】
：
BIT Life Sciences 1st Annual World Cancer Congess-2008(2008中
论文部分内容阅读
Monitoring of minimal residual disease (MRD) has become a strong diagnostic tool in acute lymphoblastic leukemia (ALL).It is used for risk adapted therapy and for the recognition of pending relapses.In acute myeloid leukemia (AML), there is still a need for more suitable MRD markers.A stepwise approach which combined genome wide expression profiling and a TaqMan realtime PCR based screening was used to identify new markers for the monitoring of MRD in AML.Leukemic cells from 52 children with AML were analyzed.Seven genes were identified which are vastly overexpressed in many patients with AML compared to healthy bone marrow: CCL23, GAGED2, MSLN, SPAG6, and ST18 as well as the previously described markers WT1 and PRAME.The expression of all genes decreased to normal levels in patients who achieved a continuous complete remission.Elevated levels of at least one gene were found prior to relapse in 7 out of 10 patients who relapsed.This set of genes should allow a sensitive and specific monitoring of MRD in AML.Notably, some of these markers couldalso serve as therapeutic targets or might be involved in leukemogenesis.MSLN is already used as a target for immunotherapy in clinical trials in other malignancies.In the ongoing multi center study AML-BFM-2004 for pediatric AML we are prospectively analyzing the prognostic relevance of this MRD monitoring.So far samples of 72 patients were analyzed.
其他文献
Despite compelling preclinical data, only anecdotal reports have shown that zoledronic acid (ZOMETA, Zol) exerts an anti-multiple myeloma (MM) effect in humans.We postulate that this could be related
Over the past decade, the important role of different growth factors and their receptors and signal transduction pathways in the genesis and progression of tumors has been well recognized and their me
Wide availability of systemic therapy agents has led to a considerable decline in the mortality from breast cancer.However, the biology of breast cancer remains poorly understood.Currently, highly acc
Brain tumours remain an important cause of morbidity and mortality and affect an increasing percentage of aging adults with a crude incidence rate of 8 per 100,000 inhabitants in Europe.Diagnosis usin
We previously identified and characterized a murine BTB-containing protein, CIBZ (ZBTB38 in human), that interacts with CtBP and binds to methylated CpGs.However, its physiological function remained u
Transcription factor NF-B plays a pivotal role in many aspects of human cancer.Two major NF-B regulation pathways have been defined: the canonical pathway and the alternative pathway.A primary step in
The scientific literature indicating that oxidative stressis unhealthy and leads to serious disease is compelling.Increased oxidative stress generally describes a condition in which cellular antioxida
Intratumor BCG administration eradicates local as well as metastasized tumors.Administration of BCG into noncancerous tissues, however, results in no effect on the tumors.Inflammation induced by BCG i
CD40 ligation has been shown to promote antigen-presenting functions of dendritic cells, which express CD40 receptor.Here we reported significantly altered biodistribution and immune responses with th
Introduction: Fluorescence in situ hybridization (FISH) is a valuable tool in clinical practice of cancer.However, high false positive and negative rates complicate the interpretation of results.Cytol